Syndax Pharmaceuticals (SNDX)
(Delayed Data from NSDQ)
$21.06 USD
+0.49 (2.38%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $21.05 -0.01 (-0.05%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Earnings News For SNDX
-
Syndax: Q4 Earnings Snapshot
-
Syndax: Q4 Earnings Snapshot
-
Syndax Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update
-
Syndax: Q3 Earnings Snapshot
-
Syndax Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Clinical and Business Update
-
Syndax Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Clinical and Business Update
-
Syndax: Q1 Earnings Snapshot
-
Syndax Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Clinical and Business Update
-
Syndax: Q4 Earnings Snapshot
-
Syndax: Q4 Earnings Snapshot
-
Syndax Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical and Business Update
-
Syndax (SNDX) to Report Q4 Earnings: What's in the Cards?
-
Syndax: Q3 Earnings Snapshot
-
Syndax Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Clinical and Business Update
-
Syndax: Q2 Earnings Snapshot
-
Syndax Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Clinical and Business Update
-
Syndax Pharmaceuticals (SNDX) Reports Q1 Loss, Lags Revenue Estimates
-
Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Misses Revenue Estimates
-
Earnings Preview: Syndax Pharmaceuticals (SNDX) Q2 Earnings Expected to Decline
-
Syndax Pharmaceuticals (SNDX) Reports Q1 Loss, Misses Revenue Estimates
-
Syndax Pharmaceuticals (SNDX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
-
Syndax Pharmaceuticals (SNDX) Reports Q4 Loss
-
Syndax Pharmaceuticals (SNDX) Reports Q3 Loss, Misses Revenue Estimates
-
Will Syndax Pharmaceuticals (SNDX) Report Negative Q3 Earnings? What You Should Know
-
Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Lags Revenue Estimates